Search

Search bills, members, committees and pages...

H.R. 8667

U.S. HouseIn House Committee

Summary

H.R. 8667, the MISSION Rx Act, was introduced in the House on May 7, 2026 by Rep. Eugene Vindman (D) with 15 co-sponsors. It was referred to Veterans' Affairs, and last saw action on May 7, 2026: Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


Record

Text

H.R. 8667 has 15 co-sponsors.

hb8667/introduced-in-house.txt
119 HR 8667 IH: Maximizing Individual Savings for Servicemembers In Obtaining Negotiated Rx Act
U.S. House of Representatives
2026-05-07
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 2d Session H. R. 8667 IN THE HOUSE OF REPRESENTATIVES May 7, 2026 Mr. Vindman (for himself, Mr. Ryan , Ms. Houlahan , Mr. Keating , Ms. Goodlander , Mr. Deluzio , and Mr. Moulton ) introduced the following bill; which was referred to the Committee on Veterans' Affairs , and in addition to the Committee on Armed Services , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL
To amend titles 10 and 38, United States Code, to set the maximum cost-sharing amount paid by an eligible covered beneficiary under the TRICARE program and a veteran for such selected drug, as established under the Social Security Act, and the maximum price of a selected drug procured by Federal agencies, and for other purposes.
1.
Short title
This Act may be cited as the Maximizing Individual Savings for Servicemembers In Obtaining Negotiated Rx Act or the MISSION Rx Act .
2.
Maximum price for a selected drug for the cost-sharing amount paid by an eligible covered beneficiary under TRICARE and a veteran and for Federal procurement
(a)
Pharmacy benefits program
Section 1074g of title 10, United States Code, is amended—
(1)
in subsection (a)(6), by adding at the end the following new subparagraphs:
(F)
Notwithstanding subparagraphs (A), (B), and (C), during any year a selected drug is covered under the Drug Price Negotiation Program established under section 1191 of the Social Security Act ( 42 U.S.C. 1320f ), the cost-sharing amount under this subsection during a year for such selected drug for an eligible covered beneficiary may not exceed the cost-sharing amount paid by a Medicare beneficiary for such selected drug in that year under part D of title XVIII of that Act ( 42 U.S.C. 1395w–101 et seq. ) pursuant to such Drug Price Negotiation Program.
; and
(2)
in subsection (i), by adding at the end the following new paragraph:
(5)
The term selected drug has the meaning given such term in section 1192(c) of the Social Security Act ( 42 U.S.C. 1320f–1(c) ).
.
(b)
Copayment for medications
Section 1722A of title 38, United States Code, is amended by adding at the end the following new subsections:
(d)
Notwithstanding subsections (a) and (b), during any year a selected drug is covered under the Drug Price Negotiation Program established under section 1191 of the Social Security Act ( 42 U.S.C. 1320f ), the copayment amount determined under this section during a year for such selected drug for a veteran may not exceed the copayment amount paid by a Medicare beneficiary for such selected drug in that year under part D of title XVIII of that Act ( 42 U.S.C. 1395w–101 et seq. ) pursuant to such Drug Price Negotiation Program.
(e)
In this section, the term selected drug has the meaning given such term in section 1192(c) of the Social Security Act ( 42 U.S.C. 1320f–1(c) ).
.
(c)
Limitation on prices of drugs procured by Department and certain other Federal agencies
Section 8126 of title 38, United States Code, is amended—
(1)
in subsection (a)—
(A)
in paragraph (3), by striking ; and and inserting a semicolon;
(B)
in paragraph (4)(C), by striking the period and inserting ; and ; and
(C)
by adding at the end the following new paragraph:
(5)
with respect to each selected drug of the manufacturer procured by a Federal agency, as described in subsection (b), such master agreement shall be subject to the requirements in subsection (j).
.
(2)
in subsection (g)(1), by striking 1992 and inserting 1992, except with respect to any reference to a provision of such Act in paragraphs (7) and (8) of subsection (h) and in subsection (j) ;
(3)
in subsection (h)—
(A)
by redesignating paragraphs (5) and (6) as paragraphs (6) and (8), respectively;
(B)
by inserting after paragraph (4) the following new paragraph:
(5)
The term maximum fair price has the meaning given such term in section 1191(c)(3) of the Social Security Act ( 42 U.S.C. 1320f(c)(3) ).
; and
(C)
by inserting after paragraph (6), as redesignated by subparagraph (A), the following new paragraph:
(7)
The term selected drug has the meaning given such term in section 1192(c) of the Social Security Act ( 42 U.S.C. 1320f–1(c) ).
; and
(4)
by adding at the end the following new subsections:
(j)
During any year a selected drug is covered under the Drug Price Negotiation Program established under section 1191 of the Social Security Act ( 42 U.S.C. 1320f ), each manufacturer entering into a master agreement may not set the maximum price for such selected drug included in such master agreement at the time such master agreement is executed at a price exceeding the maximum fair price for such drug as set by such Drug Price Negotiation Program for the duration of such master agreement.
.
(d)
Application
(1)
In general
The amendments made in subsection (c) shall apply with respect to each master agreement under section 8126 of title 38, United States Code, covering a selected drug, as defined by such section, that is in effect on the date of the enactment of this Act or enters into force on or after such date.
(2)
Termination of the Drug Price Negotiation Program
Upon termination of the Drug Price Negotiation Program established under section 1191 of the Social Security Act ( 42 U.S.C. 1320f ), each master agreement described in paragraph (1) shall be modified to reflect the drug price maximums as of the date of such modification under existing law for each selected drug, as defined in section 8126 of title 38, United States Code, as amended by subsection (c).
(e)
Conforming amendments
Part E of the Social Security Act ( 42 U.S.C. 1320f et seq. ) is amended—
(1)
in section 1193(a)(4)(A), by striking 8126(h)(5) and inserting 8126(h) ; and
(2)
in section 1194(c)(6), by striking 8126(h)(5) and inserting 8126(h) .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2026-05-07
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

To amend titles 10 and 38, United States Code, to set the maximum cost-sharing amount paid by an eligible covered beneficiary under the TRICARE program and a veteran for such selected drug, as established under the Social Security Act, and the maximum price of a selected drug procured by Federal agencies, and for other purposes.

Sponsors

Rep. Eugene Vindman (D) sponsors H.R. 8667, and 15 members have co-sponsored it, 6 of them from the day it was introduced.

Committees

H.R. 8667 went before 2 committees: Armed Services and Veterans' Affairs.

Armed Services
Armed Services
Referred To · May 7, 2026 · 581 Bills
Veterans' Affairs
Veterans' Affairs
Referred To · May 7, 2026 · 285 Bills

Actions

H.R. 8667 has taken 2 actions since May 7, 2026.

ChamberAction
May 7, 2026
House
Introduced in House
May 7, 2026
House
Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Veterans' Affairs Committee

Votes

H.R. 8667 has not gone to a roll call.

Titles

H.R. 8667 goes by 4 titles, 2 of them short titles.

  • MISSION Rx Act — Display Title
  • To amend titles 10 and 38, United States Code, to set the maximum cost-sharing amount paid by an eligible covered beneficiary under the TRICARE program and a veteran for such selected drug, as established under the Social Security Act, and the maximum price of a selected drug procured by Federal agencies, and for other purposes. — Official Title as Introduced
  • MISSION Rx Act — Short Title(s) as Introduced
  • Maximizing Individual Savings for Servicemembers In Obtaining Negotiated Rx Act — Short Title(s) as Introduced

Lobbying

1 client hired 1 firm and 7 registered lobbyists who named H.R. 8667 in 1 quarterly filing, 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Budget/Appropriations, Civil Rights/Civil Liberties, Defense, Education, Government Issues, Health Issues, Housing, Medical/Disease Research/Clinical Labs.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
PARALYZED VETERANS OF AMERICADistrict of Columbia11

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
PARALYZED VETERANS OF AMERICA11

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
PARALYZED VETERANS OF AMERICAPARALYZED VETERANS OF AMERICA2026 second_quarter$112.1K2nd Quarter - Report

Classification

The Congressional Research Service files H.R. 8667 under Armed Forces and National Security, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 8667’s is Armed Forces and National Security.

hr8667/policy-areas.txt
Armed Forces and National SecurityAgriculture and FoodAnimalsArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHealthHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 8667, as entered in the Congressional Record.

[Congressional Record Volume 172, Number 78 (Thursday, May 7, 2026)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. VINDMAN:H.R. 8667.Congress has the power to enact this legislation pursuantto the following:Article I, Sec. 8, Clause 1[Page H3342]

Source: congress.gov · legiscan.com